Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nutex Health (NUTX) Shares Outstanding (2016 - 2025)

Nutex Health's Shares Outstanding history spans 16 years, with the latest figure at $7.1 million for Q4 2025.

  • For Q4 2025, Shares Outstanding rose 28.58% year-over-year to $7.1 million; the TTM value through Dec 2025 reached $7.1 million, up 28.58%, while the annual FY2025 figure was $7.1 million, 28.58% up from the prior year.
  • Shares Outstanding for Q4 2025 was $7.1 million at Nutex Health, up from $6.9 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $660.7 million in Q2 2023 and bottomed at $4.0 million in Q4 2021.
  • The 5-year median for Shares Outstanding is $6.3 million (2025), against an average of $220.0 million.
  • The largest YoY upside for Shares Outstanding was 12650.46% in 2021 against a maximum downside of 99.33% in 2021.
  • A 5-year view of Shares Outstanding shows it stood at $4.0 million in 2021, then rose by 9.69% to $4.3 million in 2022, then grew by 4.07% to $4.5 million in 2023, then rose by 22.17% to $5.5 million in 2024, then rose by 28.58% to $7.1 million in 2025.
  • Per Business Quant, the three most recent readings for NUTX's Shares Outstanding are $7.1 million (Q4 2025), $6.9 million (Q3 2025), and $6.6 million (Q2 2025).